We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01403480
First Posted: July 27, 2011
Last Update Posted: July 27, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Rambam Health Care Campus
July 26, 2011
July 27, 2011
July 27, 2011
January 2008
December 2010   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions
Rates of Positive BCCs in Re-excisions
Basal Cell Carcinoma (BCC) is the most common malignant growth in the world. Treatment is primarily surgical with the goal of excising the growth in its entirety. When pathology results show that this has not been achieved, a re-excision is routinely performed. This study examines retrospectively the percentage of re-excisions of BCC that actually proved to be positive (exhibited growth) among those re-excisions performed at Rambam Healthcare Campus and Zvulun Community Medical Center during the years 2008-10.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample
All patients that underwent an incomplete BCC excision during the years 2008-2010.
Basal Cell Carcinoma
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
600
February 2011
December 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

All patients that underwent an incomplete BCC excision during the years 2008-2010.

Exclusion Criteria:

Patients that underwent an incomplete BCC excision and were subsequently referred to undergo a MOHS procedure.

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01403480
0064-11-RMB-CTIL
No
Not Provided
Not Provided
Prof. Yehuda Ullmann, Head, Plastic and Reconstructive Surgery Department, Rambam Healthcare Campus
Rambam Health Care Campus
Not Provided
Not Provided
Rambam Health Care Campus
February 2011